Summary of publications and clinical results

  • Sun protection

DNA photoproducts released by repair in biological fluids as biomarkers of the genotoxicity of UV radiation

Reynaud, N., Belz, L., Béal, D., Bacqueville, D., Duplan, H., Géniès, C., Questel, E., Josse, G., & Douki, T.
Analytical and bioanalytical chemistry
2022
View publication
  • Sun protection

MS imaging and absorption methods visualizing sun filter skin spatial distribution and penetration

Jacques, C., Crépel, F., El Assad, D., Angerer, T. B., Bour, J., Jeanjean-Miquel, C., Redoules, D., Bacqueville, D., Pamelard, F., Bessou-Touya, S., Frache, G., & Duplan, H.
Journal of controlled release
2022
View publication
  • Sun protection

Formulation of a new broad-spectrum UVB + UVA and blue light SPF50+ sunscreen containing Phenylene Bis-Diphenyltriazine (TriAsorB), an innovative sun filter with unique optical properties.

Bacqueville, D., Jacques-Jamin, C., Lapalud, P., Douki, T., Roullet, N., Sereno, J., Redoulès, D., Bessou-Touya, S., & Duplan, H.
Journal of the European Academy of Dermatology and Venereology
2022
View publication
  • Sun protection

Phenylene Bis-Diphenyltriazine (TriAsorB), a new sunfilter protecting the skin against both UVB + UVA and blue light radiations

Bacqueville, D., Jacques-Jamin, C., Dromigny, H., Boyer, F., Brunel, Y., Ferret, P. J., Redoulès, D., Douki, T., Bessou-Touya, S., & Duplan, H.
Photochemical & photobiological sciences
2021
View publication
  • Healing

Tolerance and efficacy of CICALFATE+ SPF50+ Multi-protective skin repair cream​

Tolerance and efficacy of CICALFATE+ multi-protective repair cream SPF50+ as monotherapy on infants, children and adults with irritated skin, under dermatological control.
  • Rosacea

Efficacy of ROSAMED Chronic redness concentrate - Comparative study on half-face (treated vs untreated)

Efficacy of ROSAMED Chronic redness concentrate in adults with mild to moderate erythrotelangiectatic rosacea, under dermatological control
Comparative half-face study (treated versus untreated)